Chicago Atlantic Real Estate Finance, Inc. (REFI) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a mixed sentiment. Financial performance shows some weaknesses, with decreased net interest income and increased interest expenses, but the company maintains a strong pipeline and strategic positioning in the cannabis sector. The Q&A reveals some uncertainties, particularly around specific loans and management's reluctance to provide detailed updates. The market sentiment is cautiously optimistic due to potential regulatory benefits and strategic moves, but the lack of clear guidance and rising leverage tempers positive expectations. Overall, the stock price is likely to remain stable, with no significant catalysts for strong movement.
Key Financial Performance
Loan Portfolio Principal $414 million as of March 31, 2026, across 25 portfolio companies. Weighted average yield to maturity was 15.8%, compared to 16.3% in Q4 2025. The decrease in yield was not explicitly explained.
Gross Originations $54 million of principal fundings in Q1 2026, with $16.2 million funded to new borrowers and $37.8 million to existing borrowers.
Repayments $52 million in repayments during Q1 2026, including $3.3 million in scheduled amortization payments and $48.2 million from full and partial loan prepayments.
Risk Rating 10.7% of the portfolio was risk-rated 4 or higher as of March 31, 2026, compared to 4.8% as of December 31, 2025. The increase was primarily due to loan #36 being downgraded from 3 to 4, contributing to an increase in CECL reserves of $3.8 million.
Nonaccrual Status 4.8% of the portfolio was on nonaccrual status as of March 31, 2026, a decrease from 11.1% as of December 31, 2025. This improvement was primarily due to loan #9 being restored to accrual status after sustained performance improvement.
Loan Composition 35.2% of loans were fixed rate and 64.8% were floating rate as of March 31, 2026. 71.9% of floating rate loans were benchmarked to the prime rate, and 28.1% to SOFR. Approximately 4% of loan principal was exposed to further rate declines.
Leverage Total leverage was 38% of book equity as of March 31, 2026, compared to 32% as of December 31, 2025.
Net Interest Income $13.1 million for Q1 2026, an 8% decrease from $14.2 million in Q4 2025. The decrease was primarily due to the Q4 collection of $1.7 million in past due unaccrued interest on loan #9.
Interest Expense $2 million in Q1 2026, up from $1.8 million in Q4 2025. The increase was due to higher weighted average borrowings on the revolving loan, which rose to $48 million from $33.6 million.
CECL Reserve $8.7 million as of March 31, 2026, representing 2.1% of outstanding loan principal. The reserve increased by $3.8 million from Q4 2025, primarily due to increases in LTV for loans #4, #34, and #36.
Distributable Earnings Per Share $0.47 (basic) and $0.46 (fully diluted) for Q1 2026.
Book Value Per Share $14.39 as of March 31, 2026.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Cannabis Ecosystem Capital Provision: Chicago Atlantic continues to be a leading capital provider in the cannabis ecosystem, leveraging expertise and relationships to redeploy capital quickly.
Federal Policy Changes: The Department of Justice rescheduled certain medical marijuana products to Schedule III from Schedule I, marking a significant federal policy change. This is expected to eliminate extra tax burdens on cannabis companies, improve operator cash flows, strengthen balance sheets, and enhance credit profiles of borrowers.
Pipeline of Cannabis Opportunities: The pipeline remains strong at $482 million, with $133 million backed by real estate collateral.
Loan Portfolio Performance: As of March 31, 2026, the loan portfolio principal totaled $414 million across 25 companies, with a weighted average yield to maturity of 15.8%. Gross originations were $54 million, offset by $52 million in repayments.
Risk Management: Approximately 10.7% of the portfolio is risk-rated 4 or higher, up from 4.8% in December 2025. CECL reserves increased by $3.8 million due to specific loan downgrades.
Nonaccrual Loans: Nonaccrual loans decreased to 4.8% of the portfolio from 11.1% in December 2025, primarily due to the restoration of loan #9 to accrual status.
Loan Structure: The portfolio consists of 35.2% fixed-rate loans and 64.8% floating-rate loans, with structural advantages such as rate floor protections.
Regulatory Adaptation: Chicago Atlantic is preparing for potential broader policy shifts in cannabis regulation, including the rescheduling of adult-use products.
Dividend Strategy: The company maintains a dividend payout ratio of 90%-100% of distributable earnings and plans for a special dividend if required by taxable income.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Private Credit Market Concerns: Continuing concerns in the private credit market could impact the company's ability to secure favorable financing terms or maintain liquidity.
Interest Rate Volatility: The Federal Reserve's pause in the interest rate easing cycle and previous rate cuts may create uncertainty in the lending environment, potentially affecting loan performance and profitability.
Middle East Conflict: Volatility caused by geopolitical tensions in the Middle East could indirectly impact market stability and investor confidence.
Cannabis Industry Regulatory Changes: Uncertainty around the implementation of federal policy changes, including the rescheduling of medical marijuana, could lead to varied impacts on operators and borrowers, depending on their market exposure.
Loan Portfolio Risk: Approximately 10.7% of the loan portfolio is risk-rated 4 or higher, indicating elevated risk levels for certain loans, which could lead to increased credit losses.
Nonaccrual Loans: 4.8% of the portfolio is on nonaccrual status, which, while improved, still represents a risk to income stability.
Interest Rate Exposure: Approximately 4% of the loan principal is exposed to further rate declines, which could impact revenue from floating rate loans.
Leverage Increase: Total leverage increased to 38% of book equity, which could heighten financial risk in a volatile market environment.
CECL Reserve Increase: The reserve for expected credit losses increased by $3.8 million, reflecting higher risk in specific loans, which could impact financial performance.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Pipeline of cannabis opportunities: The pipeline remains strong at $482 million, with approximately $133 million backed by real estate collateral.
Federal policy changes on cannabis: The Department of Justice announced rescheduling certain medical marijuana products to Schedule III from Schedule I, potentially improving operator cash flows, strengthening balance sheets, and driving higher valuation multiples. An administrative hearing is scheduled for June 29 to July 15, which could lead to broader rescheduling of cannabis products.
Regulatory-driven credit improvements: The company remains conservative, underwriting investments assuming no regulatory-driven credit improvements, but is forecasting a range of outcomes from the rule-making process.
Dividend payout ratio: The company expects to maintain a dividend payout ratio of 90% to 100% for the 2026 tax year, with a potential special dividend in the fourth quarter if taxable income requires additional distributions.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend payout ratio: Expected to maintain a dividend payout ratio based on basic distributable earnings per share of 90% to 100% for the 2026 tax year.
Special dividend: If taxable income requires additional distributions in excess of the regular quarterly dividend, a special dividend is expected in the fourth quarter.
Dividend history: Since inception, the company has distributed $8.94 per common share in dividends, representing a yield on cost of approximately 11.8% when measured against the IPO price.
Recent dividend: Distributed the fourth quarter dividend of $0.47 per common share declared by the Board in April.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide more details on loan #36, particularly its context and performance?
A:Loan #36 is an Illinois loan worth $27 million. The Illinois market is experiencing consolidation in retail and increased competition in cultivation. The loan has strong real estate coverage and is with a vertically integrated operator. Discussions with the borrower are constructive, and management expects performance improvement. The reserving activity reflects a conservative evaluation of portfolio performance and risk.
Q:What is the update on loans #4 and #34?
A:Management stated that these loans continue to evolve, but it is too early to provide specific updates. They described the relationships as constructive.
Q:What is the potential for loans in the portfolio to be equitized or for new buyers to be brought in?
A:Loan #9, which underwent a judicial foreclosure process, contrasts with other reserving activities. The market for challenged assets has improved significantly, creating a better environment for deploying capital, finding new equity investors, executing operational changes, or working towards exits.
Q:What is driving the $48 million unscheduled repayment in Q1 and $15 million in Q2?
A:These repayments are part of the normal course of business. While labeled as unscheduled, they were not surprises, as many of these loans were nearing their maturity dates.
Q:Can you comment on loan #45 in Canada and opportunities in international markets?
A:Loan #45 is not the first loan executed outside the U.S. by Chicago Atlantic. The Canadian market has stabilized and rationalized, creating opportunities for profitable operators to rise and for lenders to provide capital at strong risk-adjusted returns. Similar opportunities may arise in other oversaturated markets after rationalization.
Q:What percentage of the portfolio is medical, and how is it determined?
A:Most borrowers operate both medical and adult-use sales, often from the same dispensary. Management has not published the medical versus adult-use breakdown but hopes that by 2026, this distinction will become irrelevant due to regulatory changes.
Q:Was the CECL reserve increase in the quarter specific or general, and what is the impact of Schedule III rescheduling?
A:The reserve activity was a mix of specific and general reserves, reflecting market conditions as of 3/31. Rescheduling is seen as a credit positive for borrowers, and CECL releases may occur as market sentiment and inputs improve.
Q:Will you adjust underwriting for medical-only states if adult-use rescheduling is delayed?
A:Yes, underwriting will reflect the different tax treatments and cash flow dynamics of medical versus adult-use revenues if adult-use rescheduling is delayed.
Q:What is the potential impact of the hemp ban on the legal cannabis market?
A:Anecdotal feedback suggests the hemp ban has driven revenue increases in states with prevalent black market hemp and cannabis-adjacent products. However, direct links in the data are difficult to establish.
Q:What is the timing for pipeline transactions to come to fruition with available liquidity?
A:The pipeline refreshes every 3 to 6 months, and it is difficult to forecast deployment within that timeframe. Management has provided a breakdown of real estate-backed versus non-real estate loans to give investors better insight into the pipeline.
Q:Review of Unclear Management Responses
A:Management avoided providing specific updates on loans #4 and #34, stating it was too early to comment. Additionally, they did not provide a clear breakdown of the portfolio's medical versus adult-use composition, citing hopes for regulatory changes to make the distinction irrelevant.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Atlantic REIT
Atlantic Real
Chicago Atlantic
Chief Officer
Estate Finance
III
Manager LLC
President
REFI
REIT Manager
Real Estate
Sack Co
borrower
cannabis industry
credit facility
filing SEC
hearing
interest rate
law
loan portfolio
loan rate
measure
model
mortgage
operator
order
outcome
payment
policy change
rate loan
shift
state cannabis
REFI Transcript
Chicago Atlantic Real Estate Finance, Inc. (REFI) Q1 2026 Earnings Call Transcript
Unknown5-7
The earnings call presents a mixed sentiment. Financial performance shows some weaknesses, with decreased net interest income and increased interest expenses, but the company maintains a strong pipeline and strategic positioning in the cannabis sector. The Q&A reveals some uncertainties, particularly around specific loans and management's reluctance to provide detailed updates. The market sentiment is cautiously optimistic due to potential regulatory benefits and strategic moves, but the lack of clear guidance and rising leverage tempers positive expectations. Overall, the stock price is likely to remain stable, with no significant catalysts for strong movement.
Chicago Atlantic Real Estate Finance, Inc. (REFI) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call summary reflects stable financial performance with a slight increase in distributable earnings and book value per share. However, the Q&A reveals uncertainties in pipeline timing and market competition, along with challenges in Arizona. Despite a 50% increase in the pipeline, no pricing changes are noted. The company's conservative approach to loan #9 and stable CECL reserve suggest cautious optimism. Overall, the mixed signals and lack of clear guidance lead to a neutral sentiment.
5N Plus Inc. (VNP:CA) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call presents a positive outlook with strong financial performance, including reduced net debt and high gross margins. Although Q4 guidance indicates a temporary EBITDA decline, optimistic growth in the cannabis pipeline and strategic credit facility extensions support long-term growth. The Q&A reveals no significant supply chain issues and expectations of future margin tailwinds, despite management's vague response on gross margins. The positive sentiment outweighs concerns, indicating a likely positive stock price movement.
Pet Valu Holdings Ltd. (PET:CA) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call summary indicates positive developments, such as increased cannabis pipeline, credit facility extension, and dividend payout expectations. Despite some uncertainties in the Q&A, the company's strategic plans and financial health appear robust. The positive aspects outweigh the negatives, suggesting a likely positive stock price reaction.
REFI Slides
Chicago Atlantic Q4 2025 slides: cannabis REIT highlights 16% yield amid earnings miss2026-03-12
Chicago Atlantic Q3 2025 slides: Cannabis REIT maintains 16.5% yield despite earnings miss2025-11-04
Chicago Atlantic Q2 2025 slides: Cannabis REIT reports improved interest income amid market challenges2025-08-07
Chicago Atlantic Q1 2025 slides: cannabis REIT reports mixed results amid industry challenges2025-05-07
REFI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
